MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Location
Founded
1989-12-19
Website
Risk Signals
4960 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2025-02-21 (investorshangout.com)
Celebrating Corporate Responsibility: Medtronic and Webster Bank - Investors Hangout
The Conference Board recognizes Medtronic and Webster Bank for their exemplary corporate responsibility efforts, highlighting their impact on sustainability and society.
Read more
2025-02-18 (drugdeliverybusiness.com)
Medtronic seeks to expand MiniMed 780G label to type 2 diabetes, submits new CGM to FDA
Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin delivery platform.
Read more
2025-01-18 (medtechdive.com)
JPM25 recap: Robotics, PFA and OTC glucose sensors in the spotlight |
CEOs from Medtronic, Intuitive Surgical, Boston Scientific and Dexcom were on hand this week in San Francisco to discuss the year ahead at the J.P. Morgan Healthcare Conference.
Read more
2025-01-17 (drugdeliverybusiness.com)
Medtronic says it has next-gen insulin pumps on the way, more to come from diabetes business
The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.
Read more
2025-01-15 (medtechdive.com)
CEO Geoff Martha tells JPM crowd Medtronic is ‘stacking growth drivers’ |
New technologies for atrial fibrillation, hypertension, diabetes and neurological conditions are poised for fast growth, Martha said Monday at the J.P. Morgan Healthcare Conference.
Read more
2025-01-15 (biovoicenews.com)
Medtronic APAC Innovation Conference-min -
Image-Panelists at the Medtronic APAC Innovation Conference discuss about barriers to accelerating healthcare technology adoption.
Read more
2025-01-08 (thailand-business-news.com)
Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference - Thailand Business News
GALWAY, Ireland, Jan. 7, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the
Read more
2025-01-07 (manilatimes.net)
Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference |
GALWAY, Ireland, Jan. 7, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 43rd annual J.P. Morgan healthcare conference on Monday, January 13, 2025.
Read more
2025-01-07 (weeklyvoice.com)
Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference -
GALWAY , Ireland , Jan. 6, 2025 /CNW/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 43rd
Read more
2025-01-07 (scitechanddigital.news)
Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference - SDN - Science & Digital News
GALWAY, Ireland, Jan. 7, 2025 /PRNewswire/ — Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 43rd annual J.P. Morgan healthcare conference on…
Read more
2025-01-06 (stocktitan.net)
Medtronic CEO to Present Vision at J.P. Morgan Healthcare Conference 2025 | MDT Stock News
Geoff Martha, Medtronic's CEO, will share insights at JPM Healthcare Conference. Global leader serves 70 health conditions across 150 countries, impacting two lives every second.
Read more
2024-12-02 (cardiovascularbusiness.com)
Medtronic TAVR valves at heart of key studies presented during PCR London Valves 2024
One study presented during the three-day conference focused on the potential benefits of an optimized TAVR pathway. Another study, meanwhile, tracked changes in paravalvular leak severity over time.
Read more